SARAH LOCHREN: Open Payments
NPI 1497007009 · OCEAN SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,250 in 106 payments from 37 companies in 2025. Trend: 2023 $28 · 2024 $838 · 2025 $2,250
Food & beverage: $2,234Education: $16
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 11 | $240 |
| AstraZeneca Pharmaceuticals LP | 13 | $230 |
| Novartis Pharmaceuticals Corporation | 9 | $180 |
| Celgene Corporation | 5 | $139 |
| Incyte Corporation | 6 | $131 |
| Janssen Biotech, Inc. | 6 | $118 |
| Genentech USA, Inc. | 5 | $98 |
| BeOne Medicines USA, Inc. | 4 | $90 |
| PharmaEssentia USA Corporation | 3 | $90 |
| ABBVIE INC. | 3 | $76 |
Products named: KEYTRUDA, REBLOZYL, BRUKINSA, JAKAFI, CALQUENCE, BESREMI, CABOMETYX, CARVYKTI.
Industry payments across MS — which companies pay providers there.
